THROMBATE III® (antithrombin III [human]) is indicated in patients with hereditary antithrombin deficiency for treatment and prevention of thromboembolism and for prevention of perioperative and peripartum thromboembolism.

2022年11月15日 · Thrombate III (Antithrombin III [Human]) is a form of protein found in the blood used to treat patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism. What Are Side Effects of Thrombate? Thrombate may cause serious side effects including: hives,

2023年12月13日 · THROMBATE III, Antithrombin III (Human), is a sterile, non-pyrogenic concentrate of human antithrombin (AT) in lyophilized powder form for reconstitution for intravenous injection. When reconstituted with Sterile Water for Injection, USP, THROMBATE III has a pH of 6.0 to 7.5 and contains 110 mEq/L to 210 mEq/L sodium, 110 mEq/L to 210 mEq/L ...

Antithrombin III (Human, Grifols)是由Grifols Sa研发的一种非重组酶，是一种F10抑制剂。 目前该药物最高研发阶段为批准上市，用于治疗抗凝血酶Ⅲ缺乏和血栓栓塞。

Medscape - Indication-specific dosing for Thrombate III (antithrombin III), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules,...

THROMBATE III® (antithrombin III [human]) is indicated in patients with hereditary antithrombin deficiency for treatment and prevention of thromboembolism and for prevention of perioperative and peripartum thromboembolism.

THROMBATE III® (antithrombin III [human]) is indicated in patients with hereditary antithrombin deficiency for treatment and prevention of thromboembolism and for prevention of perioperative and peripartum thromboembolism.

2024年4月10日 · Short-term replacement therapy for prevention or treatment of thromboembolism in selected patients with congenital antithrombin III deficiency at high risk for thromboembolism (i.e., those undergoing surgical or obstetrical procedures) or those with thromboembolism. Has been designated an orphan drug by FDA for this use.

Thrombin inhibitor (α 2 -glycoprotein). Treatment of patients with hereditary antithrombin III deficiency (AT-III) in surgical or obstetrical procedures and thromboembolism. Give by IV infusion...

Class/mechanism: Inhibitor of thrombin, which converts fibrinogen to fibrin in the coagulation cascade and subsequent development of thrombus. Clinical applications include management of patients with hereditary antithrombin III (AT-III) deficiency. Please choose from the products below to find specific drug/manufacturer information: